Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.36 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.36 |
| ▸ | FDPS | P14324 | 3/20 | 0.35 |
| ▸ | LMNA | P02545 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4268661 | 1.00 | HRH3 (0.37) | HRH3L3MBTL1MAPTMAPK1NPSR1 | |
| SCHEMBL27827097 | 1.00 | HRH3 (0.37) | HRH3L3MBTL1MAPTMAPK1NPSR1 | |
| SCHEMBL27825382 | 1.00 | HRH3 (0.37) | HRH3L3MBTL1MAPTMAPK1NPSR1 | |
| SCHEMBL4275497 | 1.00 | HRH3 (0.37) | HRH3L3MBTL1MAPTMAPK1NPSR1 | |
| SCHEMBL29106969 | 1.00 | HRH3 (0.37) | HRH3L3MBTL1MAPTMAPK1NPSR1 | |
| SCHEMBL4275008 | 0.98 | FDPS (0.36) | HRH3L3MBTL1MAPTMAPK1NPSR1 | |
| SCHEMBL27942598 | 0.98 | FDPS (0.36) | HRH3L3MBTL1MAPTMAPK1NPSR1 | |
| SCHEMBL4267683 | 0.98 | HRH3 (0.38) | HRH3L3MBTL1MAPTMAPK1NPSR1 | |
| SCHEMBL4276675 | 0.98 | FDPS (0.36) | HRH3L3MBTL1MAPTMAPK1NPSR1 | |
| SCHEMBL2228961 | 0.98 | FDPS (0.36) | HRH3L3MBTL1MAPTMAPK1NPSR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117043136-A | Fluorine-based ionic liquid and method for producing same | 第一工业制药株式会社 | 2023-11-10 | — | — | CN | disclosed |
| US-20230312498-A1 | NON-ATP/CATALYTIC SITE p38 MITOGEN ACTIVATED PROTEIN KINASE INHIBITORS | UNIVERSITY OF MARYLAND, BALTIMORE | 2023-10-05 | — | — | US | disclosed |
| US-11718595-B2 | Non-ATP/catalytic site p38 Mitogen Activated Protein Kinase inhibitors | UNIVERSITY OF MARYLAND, BALTIMORE (US) | 2023-08-08 | — | — | US | disclosed |
| US-20210317097-A1 | NON-ATP/CATALYTIC SITE p38 MITOGEN ACTIVATED PROTEIN KINASE INHIBITORS | UNIVERSITY OF MARYLAND, BALTIMORE | 2021-10-14 | — | — | US | disclosed |
| US-7605271-B2 | Superhigh purity ionic liquid | DAI-ICHI KOGYO SEIYAKU CO., LTD (JP) | 2009-10-20 | — | — | US | disclosed |
| US-20060223995-A1 | Superhigh purity ionic liquid | DAI-ICHI KOGYO SEIYAKU CO., LTD. (JP) | 2006-10-05 | — | — | US | disclosed |
| EP-1707265-A1 | Superhigh purity ionic liquid | DAI-ICHI KOGYO SEIYAKU CO., LTD. (JP) | 2006-10-04 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20210317097-A1 | NON-ATP/CATALYTIC SITE p38 MITOGEN ACTIVATED PROTEIN KINASE INHIBITORS | MAPK1, MAPK8, MAPK4 | HRH3 3554/4885L3MBTL1 2364/4885MAPT 2165/4885 |
| US-20230312498-A1 | NON-ATP/CATALYTIC SITE p38 MITOGEN ACTIVATED PROTEIN KINASE INHIBITORS | MAPK1, MAPK8, MAPK4 | HRH3 3554/4885L3MBTL1 2364/4885MAPT 2165/4885 |
| US-11718595-B2 | Non-ATP/catalytic site p38 Mitogen Activated Protein Kinase inhibitors | MAPK1, MAPK8, MAPK4 | HRH3 3554/4885L3MBTL1 2364/4885MAPT 2165/4885 |
| US-20060223995-A1 | Superhigh purity ionic liquid | SLC7A5, SLC7A1, SLC43A1 | HRH3 709/4885L3MBTL1 1019/4885MAPT 4184/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.